6/10
09:46 am
bsgm
BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer [Yahoo! Finance]
High
Report
BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer [Yahoo! Finance]
6/10
09:45 am
bsgm
BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer
Medium
Report
BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer
5/30
04:18 pm
bsgm
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
Neutral
Report
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
5/30
04:05 pm
bsgm
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Neutral
Report
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5/30
10:08 am
bsgm
Predictive Oncology, Augmedix, Cue Health among healthcare movers [Seeking Alpha]
Low
Report
Predictive Oncology, Augmedix, Cue Health among healthcare movers [Seeking Alpha]
5/30
08:54 am
bsgm
BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
Low
Report
BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
5/30
08:00 am
bsgm
BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Medium
Report
BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5/21
11:15 am
bsgm
BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders [Yahoo! Finance]
Low
Report
BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders [Yahoo! Finance]
5/21
11:10 am
bsgm
BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders
Low
Report
BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders
5/3
12:29 pm
bsgm
BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent [Yahoo! Finance]
Medium
Report
BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent [Yahoo! Finance]
5/3
12:22 pm
bsgm
BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent
Medium
Report
BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent
4/30
02:20 pm
bsgm
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately [Yahoo! Finance]
High
Report
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately [Yahoo! Finance]
4/30
02:03 pm
bsgm
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
High
Report
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
4/4
11:43 am
bsgm
BioSig Engages Consulting Firm for Business Model Strategies [Yahoo! Finance]
Medium
Report
BioSig Engages Consulting Firm for Business Model Strategies [Yahoo! Finance]
4/4
11:35 am
bsgm
BioSig Engages Consulting Firm for Business Model Strategies
Medium
Report
BioSig Engages Consulting Firm for Business Model Strategies
3/27
07:05 pm
bsgm
Global Particle Therapy Market Analysis and Forecasts, 2023-2033 : Revolutionizing Cancer Treatment, Particle Therapy's Rise in External Beam Radiotherapy [Yahoo! Finance]
High
Report
Global Particle Therapy Market Analysis and Forecasts, 2023-2033 : Revolutionizing Cancer Treatment, Particle Therapy's Rise in External Beam Radiotherapy [Yahoo! Finance]